•
Jun 30, 2024

AMN Healthcare Q2 2024 Earnings Report

AMN Healthcare's Q2 2024 financial performance showed a decrease in revenue compared to the previous year, but strategic expense management and diversification of solutions contributed to profit margins exceeding expectations.

Key Takeaways

AMN Healthcare reported a second-quarter revenue of $741 million, a 25% decrease year-over-year. GAAP EPS was $0.42, and adjusted EPS was $0.98. The company is seeing promising signs of improvement in the travel nurse market.

Consolidated revenue for the quarter was $741 million, a 25% decrease from prior year.

Net income was $16 million, or $0.42 per diluted share.

Adjusted diluted EPS in the second quarter was $0.98.

Revenue for the Nurse and Allied Solutions segment was $442 million, lower by 36% year over year.

Total Revenue
$741M
Previous year: $991M
-25.3%
EPS
$0.98
Previous year: $2.38
-58.8%
Gross Profit
$230M
Previous year: $330M
-30.5%
Cash and Equivalents
$48M
Previous year: $7M
+585.7%
Free Cash Flow
$73M
Previous year: $171M
-57.4%
Total Assets
$2.78B
Previous year: $2.64B
+5.1%

AMN Healthcare

AMN Healthcare

AMN Healthcare Revenue by Segment

Forward Guidance

Revenue in the third quarter of 2024 is expected to be 20-23% lower than the prior year and 8-10% lower sequentially.